118 related articles for article (PubMed ID: 36754125)
1. Analysis of the in vitro function and internalization ability of a humanized EGFR antibody AE01 expressed by Chinese hamster ovary cells.
Wu H; Ding X; Chen Y; Cai Y; Yang Z; Xu Q; Jin J
Protein Expr Purif; 2023 Jun; 206():106243. PubMed ID: 36754125
[TBL] [Abstract][Full Text] [Related]
2. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.
Heitner T; Moor A; Garrison JL; Marks C; Hasan T; Marks JD
J Immunol Methods; 2001 Feb; 248(1-2):17-30. PubMed ID: 11223066
[TBL] [Abstract][Full Text] [Related]
3. Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro.
Yi CH; Ruan CP; Wang H; Xu XY; Zhao YP; Fang M; Ji J; Gu X; Gao CF
Acta Pharmacol Sin; 2014 Nov; 35(11):1439-46. PubMed ID: 25263334
[TBL] [Abstract][Full Text] [Related]
4. Structure and activity of an anti-epidermal growth factor receptor antibody without galactose-α-1,3-galactose residues.
Ren K; Gong H; Ma Z; Tian L; Ye W; Lv X; Wu C
Drug Dev Res; 2022 May; 83(3):637-645. PubMed ID: 34725841
[TBL] [Abstract][Full Text] [Related]
5. Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization.
Ahsan A; Hiniker SM; Davis MA; Lawrence TS; Nyati MK
Cancer Res; 2009 Jun; 69(12):5108-14. PubMed ID: 19509222
[TBL] [Abstract][Full Text] [Related]
6. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Barzegar A; Rahbarnia L
Anticancer Drugs; 2017 Mar; 28(3):263-270. PubMed ID: 27861173
[TBL] [Abstract][Full Text] [Related]
7. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
[TBL] [Abstract][Full Text] [Related]
8. Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.
Singer J; Fazekas J; Wang W; Weichselbaumer M; Matz M; Mader A; Steinfellner W; Meitz S; Mechtcheriakova D; Sobanov Y; Willmann M; Stockner T; Spillner E; Kunert R; Jensen-Jarolim E
Mol Cancer Ther; 2014 Jul; 13(7):1777-1790. PubMed ID: 24755200
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells.
Wang X; Zhu J; Zhao P; Jiao Y; Xu N; Grabinski T; Liu C; Miranti CK; Fu T; Cao BB
Cancer Biol Ther; 2007 Jun; 6(6):980-7. PubMed ID: 17534145
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.
Patel D; Lahiji A; Patel S; Franklin M; Jimenez X; Hicklin DJ; Kang X
Anticancer Res; 2007; 27(5A):3355-66. PubMed ID: 17970081
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas.
Paraskevakou G; Allen C; Nakamura T; Zollman P; James CD; Peng KW; Schroeder M; Russell SJ; Galanis E
Mol Ther; 2007 Apr; 15(4):677-86. PubMed ID: 17299404
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human IgG antibodies recognizing distinct extracellular domains of EGF receptor exhibit different degrees of growth inhibitory effects on human A431 cancer cells.
Chang C; Takayanagi A; Yoshida T; Shimizu N
Exp Cell Res; 2013 May; 319(8):1146-55. PubMed ID: 23499740
[TBL] [Abstract][Full Text] [Related]
13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
14. Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Hosono H; Takei J; Ohishi T; Sano M; Asano T; Sayama Y; Nakamura T; Yanaka M; Kawada M; Harada H; Kaneko MK; Kato Y
Int J Mol Med; 2020 Oct; 46(4):1443-1452. PubMed ID: 32945346
[TBL] [Abstract][Full Text] [Related]
15. Conditional expression of full-length humanized anti-prion protein antibodies in Chinese hamster ovary cells.
Mueller DA; Heinig L; Ramljak S; Krueger A; Schulte R; Wrede A; Stuke AW
Hybridoma (Larchmt); 2010 Dec; 29(6):463-72. PubMed ID: 21087094
[TBL] [Abstract][Full Text] [Related]
16. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
Tanaka T; Ohishi T; Saito M; Suzuki H; Kaneko MK; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):142-149. PubMed ID: 35666554
[TBL] [Abstract][Full Text] [Related]
17. A novel strategy for engineering of a smart generation of immune ribonucleases against EGFR
Taghizadegan N; Firoozrai M; Nassiri M; Ariannejad H
J Cell Physiol; 2021 Jun; 236(6):4303-4312. PubMed ID: 33421131
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into a matured humanized monoclonal antibody HuA21 against HER2-overexpressing cancer cells.
Wang Z; Cheng L; Guo G; Cheng B; Hu S; Zhang H; Zhu Z; Niu L
Acta Crystallogr D Struct Biol; 2019 Jun; 75(Pt 6):554-563. PubMed ID: 31205018
[TBL] [Abstract][Full Text] [Related]
19. Selection and characterization of an internalizing epidermal-growth-factor-receptor antibody.
Zhao X; Dai W; Cao L; Zhu H; Yu Y; Ye Q; Wang M; Dai W; Lei P; Shen G
Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):27-33. PubMed ID: 16886908
[TBL] [Abstract][Full Text] [Related]
20. XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.
Schanzer JM; Wartha K; Moessner E; Hosse RJ; Moser S; Croasdale R; Trochanowska H; Shao C; Wang P; Shi L; Weinzierl T; Rieder N; Bacac M; Ries CH; Kettenberger H; Schlothauer T; Friess T; Umana P; Klein C
MAbs; 2016; 8(4):811-27. PubMed ID: 26984378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
